Recombinant Human CBR3 Protein，His

CBR3 (Carbonyl Reductase 3) is a member of the aldo-keto reductase superfamily, playing a crucial role in the metabolic processes involving carbonyl compounds. Its importance has been underscored by research indicating its involvement in the detoxification of xenobiotics and the metabolism of various endogenous substrates, which can influence drug efficacy and toxicity. Furthermore, CBR3 has been linked to various pathological conditions, including cancer and neurodegenerative diseases, as it modulates the levels of reactive oxygen species and participates in cellular redox homeostasis. Recent studies have explored the enzyme's structural and functional characteristics, revealing insights into its substrate specificity and regulatory mechanisms. The investigation of CBR3 at the protein level, including the assessment of its recombinant forms, has become pivotal for understanding its physiological relevance and potential therapeutic applications. Recombination techniques enable the production of CBR3 in a controlled environment, allowing for detailed biochemical analyses, structure-function relationship studies, and the development of inhibitors that could serve as novel drugs. Overall, the study of CBR3 not only enhances our understanding of this enzyme's role in human health and disease but also opens new avenues for pharmacological intervention in conditions associated with dysregulated carbonyl metabolism.